
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | -- | -- | -- | -- | -- |
08/14/2025 | Q2 | -- | -- | -- | -- | -- |
05/13/2025 | Q1 | -- | -- | -$0.69 | -- | -- |
03/21/2025 | Q4 | -- | -- | $0.51 | -- | -- |
11/08/2024 | Q3 | -- | -- | -$2.85 | -- | -- |
08/14/2024 | Q2 | -- | -- | -$1.70 | -- | -- |
05/13/2024 | Q1 | -- | -- | -$2.02 | -- | -- |
03/22/2024 | Q4 | -- | -- | -$5.13 | -- | -- |
11/13/2023 | Q3 | -- | -- | -$2.82 | -$3.00 | $0.18 |
08/15/2023 | Q2 | -- | -- | -$3.02 | -$3.98 | $0.96 |
05/12/2023 | Q1 | -- | -- | -$4.13 | -- | -- |
03/22/2023 | Q4 | -- | -- | -$3.60 | -- | -- |
11/10/2022 | Q3 | -- | -- | -$4.50 | -- | -- |
08/15/2022 | Q2 | -- | -- | -$3.60 | -- | -- |
05/12/2022 | Q1 | -- | -- | -$3.60 | -- | -- |
03/24/2022 | Q4 | -- | -- | -$1.35 | -- | -- |
11/10/2021 | Q3 | -- | -- | -$2.25 | -- | -- |
08/12/2021 | Q2 | -- | -- | -$2.25 | -- | -- |
05/12/2021 | Q1 | -- | -- | -$3.00 | -- | -- |
03/24/2021 | Q4 | -- | -- | -$3.15 | -- | -- |
11/13/2020 | Q3 | -- | -- | -$4.95 | -- | -- |
08/12/2020 | Q2 | -- | -- | -$15.30 | -- | -- |
05/11/2020 | Q1 | -- | -- | -$2.25 | -- | -- |
03/19/2020 | Q4 | -- | -- | -$7.65 | -- | -- |
11/12/2019 | Q3 | -- | -- | -$8.10 | -- | -- |
08/16/2019 | Q2 | -- | -- | -$2.70 | -- | -- |
05/14/2019 | Q1 | -- | -- | -$12.60 | -- | -- |
02/21/2019 | Q4 | -- | -- | -$9.00 | -- | -- |
11/13/2018 | Q3 | -- | -- | -$7.20 | -- | -- |
08/13/2018 | Q2 | -- | -- | -$18.00 | -- | -- |
05/15/2018 | Q1 | -- | -- | -$7.20 | -- | -- |
03/28/2018 | Q4 | -- | -- | -$14.40 | -- | -- |
11/14/2017 | Q3 | -- | -- | -$12.60 | -- | -- |
08/14/2017 | Q2 | -- | -- | -$17.10 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$1.80 | -- | -- |
12/31/2016 | Q4 | -- | -- | -$10.80 | -- | -- |
11/21/2016 | Q3 | -- | -- | -$10.80 | -- | -- |
08/15/2016 | Q2 | -- | -- | -$7.20 | -- | -- |
06/16/2016 | Q1 | -- | -- | -$2.09 | -- | -- |
Moleculin Biotech reported -- worth of top line sales in its most recent quarter.
Moleculin Biotech announced earnings per share of -$0.69 which represents a miss of analyst forecast a -- per share.
Moleculin Biotech reported -- that represents -- per share over the last quarter.
Moleculin Biotech's earnings are forecast to decrease from -$6.32 per share to -$14.09 per share next year representing a decrease of -16.46%.
Moleculin Biotech's next earnings date is August 14, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.